ONCASPAR 750 U/ml, powder for solution for injection/for infusion bottle
Active ingredients: Pegaspargase
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Powder for solution for injection or infusionbottleintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ONCASPAR 750 U/ml, poudre pour solution injectable/pour perfusion
- Pharmaceutical form
- poudre pour solution injectable ou pour perfusion
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 1 flacon en verre de 3750 U
- Marketing authorisation holder
- LES LABORATOIRES SERVIER
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 29 Oct 2018
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61861579CIP75504654CIP133400955046547Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PÉGASPARGASEpoudre | 750 U · 1 mL de solution après reconstitution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.